Health Care Equipment & Services

Elevance Health insider sale shows routine RSU tax‑withdrawal, not loss of confidence, while strong fundamentals and food‑as‑medicine strategy keep the stock poised for growth.

Insider trades show Edwards Lifesciences’ CFO bullish on future growth, backing a strong pipeline and shareholder‑aligned incentives. Click to learn how this boosts long‑term value.

Insider buying at Streamex Corp. shows confidence amid a steep drop, hinting at future tech‑health breakthroughs and potential upside.

Insider sales trend & new equity award in Establishment Labs Holdings—why investors should watch Quiros’s moves and what it means for stock value.

TruBridge’s sale to IKS Health at $26.25/share shows how strategic consolidation can unlock value—learn how Pinetree Capital’s exit and IKS Health’s integration reshape the healthcare tech landscape.

Bank of America’s small stake in Bluejay Diagnostics signals cautious optimism amid a rapid‑care device surge, hinting at a potential rebound.

TruBridge’s $26.25‑per‑share buyout by IKS Health ends its independent operations, giving shareholders a cash exit and boosting IKS’s tech‑driven health‑care platform.

CEO Workman Kurt’s July sale of 21,001 Owlet shares shows routine portfolio rebalancing, not a warning, while his long‑term stake underscores confidence in Owlet’s pulse‑oximetry baby monitors.

Holgerson’s steady hold on The Cigna Group shares shows insider confidence amid high buzz, revealing a low‑risk, medium‑term growth outlook for investors.

Insight: Clover Health CEO’s July 8 insider sale is part of a planned liquidity strategy, not a sign of trouble—focus on the company’s Medicare‑advantage growth and data‑driven care edge.